Search Results - diagnostics+-+cancer

15 Results

Sort By:

Protease Activity Sensing Probes For Early Detection and Prognosis of Pancreatic Cancer

Summary The current technology is a liquid biopsy diagnostic screen for pancreatic ductal adenocarcinoma (PDAC), which is high throughput, requires very small blood volumes and has been validated in a large patient dataset. Technology Overview Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers and is typically discovered by accident...

Published: 7/31/2024 | Inventor(s): Jared Fischer, Jose Luis Montoya Mira

Keywords(s): Diagnostics, Diagnostics - Cancer

Category(s): Diagnostics

CD74 as a biomarker and therapeutic target for familial platelet (FPD) disorder

Summary Research at OHSU has identified the CD74 signaling cascade as a potential therapeutic target and diagnostic biomarker for RUNX1-mutated familial platelet disorder (FPD), which is a premalignant condition for acute myeloid leukemia. Technology Overview Current estimates suggest as many as 18,000 people may be living with RUNX1-FPD in the United...

Published: 2/27/2024 | Inventor(s): Anupriya Agarwal, Mona Mohammadhosseini

Keywords(s): Diagnostics, Diagnostics - Cancer, Diagnostics - Other, Therapeutics, Therapeutics - Cancer, Therapeutics - Other

Category(s): Diagnostics, Therapeutics

Nanoparticle ultrasound contrast agents with high acoustic activity

Summary Contrast-enhanced ultrasound allows for low-cost minimally-invasive imaging; however, the size of typical contrast reagents prevents them from penetrating tumors thereby limiting their utility for cancer diagnostic and therapeutic purposes (theranostics). Oregon Health & Science University (OHSU) researchers have developed novel nanoparticle...

Published: 11/22/2023 | Inventor(s): Adem Yildirim, Jose Luis Montoya Mira, Sadik Esener, Stuart Ibsen

Keywords(s): Diagnostics, Diagnostics - Cancer, Imaging, Imaging - Acoustic, Research Tools, Therapeutics

Category(s): Diagnostics, Imaging, Nanoscience & Microtechnologies, Research Tools, Therapeutics

Novel single-gene biomarker for acute myeloid leukemia prognosis

Summary The current technology is a novel set of biomarkers derived from the largest ever genomic and transcriptomic data set for acute myeloid leukemia (AML), which includes a novel single gene biomarker capable of strongly predicting AML prognosis. Technology Overview Acute myeloid leukemia (AML) is an aggressive hematologic malignancy with an incidence...

Published: 9/27/2023 | Inventor(s): Daniel Bottomly, Brian Druker, Kara Johnson, Stephen (Steve) Kurtz, Nicola Long, Shannon McWeeney, Anna Reister Schultz, Cristina Tognon, Jeffrey (Jeff) Tyner

Keywords(s): Diagnostics, Diagnostics - Cancer

Category(s): Diagnostics

Effective combinations of targeted agents for hematologic malignancies

Summary Current treatment strategies for acute myeloid leukemia (AML) have low efficacy rates, due in part to the complex and heterogenous underlying genetics of this cancer. Oregon Health & Science University researchers have developed a precision medicine approach for the treatment of AML by identifying an effective combination therapy for a specific...

Published: 9/27/2023 | Inventor(s): Jeffrey (Jeff) Tyner, Elie Traer, Stephen (Steve) Kurtz, Brian Druker, Andrew Kaempf, Christopher (Chris) Eide, Motomi (Tomi) Mori

Keywords(s): Diagnostics, Diagnostics - Cancer

Category(s): Diagnostics

High-throughput precision medicine screening for solid tumors

Summary The current technology provides a unique ex vivo biopsy culture method for improved and personalized screening of multiple drug combinations for solid tumors. Technology Overview Precision medicine allows for cancer therapies to be tailored to individual tumor characteristics, but current screening methods often lack the capacity to 1) capture...

Published: 9/27/2023 | Inventor(s): Joe Gray, Zuzana Tatarova, Oliver Jonas

Keywords(s): Diagnostics, Diagnostics - Cancer

Category(s): Diagnostics

Software for deep learning-based inference of biomarker distribution in cancer samples

Summary Multiplexed tissue imaging (MTI) is a powerful tool for cancer pathology, but it is also expensive, which has limited its availability for underserved communities, particularly in the developing world. The current software uses hematoxylin & eosin (H&E) staining, which is more widely available, to predict oncology biomarker distribution,...

Published: 9/27/2023 | Inventor(s): Young Hwan Chang, Erik Burlingame, Geoffrey Schau, Elliot Gray

Keywords(s): Diagnostics, Diagnostics - Cancer, Imaging, Imaging - Other, Software, Software - Diagnostic/Detection

Category(s): Diagnostics, Software

Universal nanoprobes for imaging and treatment of cancer

Summary Medical imaging is currently incapable of detecting very small tumors and there is a need for new contrast agents that allow for earlier detection of cancers. The current technology is a self-assembled nanoprobe that specifically accumulates in a broad range of solid tumors to enable 1) high-resolution imaging for earlier cancer detection and...

Published: 9/21/2023 | Inventor(s): Adem Yildirim, Jared Fischer, Bruce Branchaud

Keywords(s): Diagnostics, Diagnostics - Cancer, Imaging, Therapeutics, Therapeutics - Cancer

Category(s): Diagnostics, Imaging, Therapeutics

Label-free microfluidic device for cancer liquid biopsy

Summary Liquid biopsies offer a less invasive method of early cancer detection; however, circulating cancer cells are rare and difficult to detect. The current technology is a device that allows for sensitive, label-free enrichment of circulating neoplastic cells in order to facilitate the detection of cancer biomarkers from peripheral blood samples. Technology...

Published: 8/16/2022 | Inventor(s): Yu-Jui (Roger) Chiu, Ajay Sapre, Jose Luis Montoya Mira, Kyle Gustafson

Keywords(s): Device, Device - Other, Diagnostics, Diagnostics - Cancer, Research Tools

Category(s): Diagnostics, Research Tools, Device

Cell-free RNA biomarkers capable of distinguishing cancer from premalignant disease

Summary Early cancer detection is critical for improving long-term patient survival and highlights a need for new sensitive and minimally-invasive early detection methods. The current technology includes novel sets of cell-free RNA biomarkers that can be used to potentially distinguish between malignant and pre-malignant forms of certain cancers using...

Published: 6/15/2022 | Inventor(s): Thuy Ngo, Hyun Kim, Josiah Wagner, Breeshey Roskams-Hieter, Pavana Anur

Keywords(s): Diagnostics, Diagnostics - Cancer

Category(s): Diagnostics

1 2